|
COPYRIGHT 2005 Voxant Inc.
Original Source: CNBC/DOW JONES BUSINESS VIDEO ANALYST INTERVIEW
BILL GRIFFETH, CNBC ANCHOR: Welcome back to Making Money now here on "Power Lunch." Time for our Inside Track segment, our weekly look at legal insider trading activity among some of the nation`s top executives. Mark LoPresti the Senior Quantitative Analyst at Thompson Financial has been sorting through the SEC filings to find out which insiders have been buying or selling shares of their own company stock on a legal basis. Mark joins us from Washington. Good to see you Mark, welcome back.
MARK LOPRESTI, THOMPSON FINANCIAL: Nice to be back, Bill.
GRIFFETH: Start on the buy side, you had four insiders buying at Albany Molecular Research.
LOPRESTI: That`s correct. They bought over 460,000 shares between 8 and $9 a share. This is a biotech firm that focuses on the recent development of small-molecule prescription drugs. They also...
Read the full article for free courtesy of your local library.
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
